Our Board of Directors serve as the stewards of our organizational growth and success. A thoughtful, diverse group of accomplished leaders, our Board members are committed to our mission to promote talent in medicine.
We founded Women as One because the issues impacting women in medicine are worldwide. We must therefore join together as a global community to address them.
Marie Claude Morice, MD
Founding Director & Board Member
Marie Claude Morice, MD
Founding Director & Board Member
Marie-Claude Morice, MD, FESC is the Director of Interventional Cardiology at Institute Hospitalier Jacques Cartier. She is Founder and Co-Director of Institut Cardiovasculaire Paris-Sudserves and a Founding Medical Director and CEO of the CERC.Read Bio
Marie-Claude Morice, MD, FESC is the Director of Interventional Cardiology at Institute Hospitalier Jacques Cartier.
She is Founder and Co-Director of Institut Cardiovasculaire Paris-Sudserves and a Founding Medical Director and CEO of the Cardiovascular European Research Centre (CERC). Her research work has been widely recognized by her peers and in 2014 she was the first woman to ever receive the Geoffrey O. Hartzler Master Clinical Operator Award from the Cardiovascular Research Centre in recognition of her work in the advancement of interventional cardiology.
Dr. Morice has been Co-Director of the Endovascular Therapy Course in Paris since 1995 and is an adviser to the Ministry of Health for new technologies. She founded the PTCA program at Centre Cardiologique du Nord in 1986. She was in charge of coronary interventions in the coronary flow group of the European Society of Cardiology from 1994 to 1996 and received the Erasmus Thoraxcenter Interventional Cardiology award in 1995.
Dr. Morice completed medical school at the Paris University and received training at the University Hospital of Toulouse-Purpan and the Montreal Cardiac Institute.
ROXANA MEHRAN, MD
Founding Director & Board Member
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI is a Professor of Medicine, Cardiology, Professor of Population Health Science and Policy, and the Director of Interventional Cardiovascular Research and Clinical Trials....Read Bio
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI is a Professor of Medicine, Cardiology, Professor of Population Health Science and Policy, and the Director of Interventional Cardiovascular Research and Clinical Trials at the Icahn School of Medicine at Mount Sinai.
She is co-founder of the Academic Research Consortium (ARC) and SCAI Women in Innovations (SCAI-WIN) and is a founding physician of the Cardiovascular Research Foundation (CRF), where she is currently Chief Scientific Officer. She has served as principal investigator for numerous large global clinical studies, developed risk scores for bleeding and acute kidney injury, and authored 900 peer-reviewed articles.
Dr. Mehran has received numerous prestigious awards, most recently the 2018 Wenger Award for Excellence in Medical Leadership from WomenHeart: The National Coalition of Women with Heart Disease. Prior to Mount Sinai, Dr. Mehran held appointments at Columbia University Medical Center and Washington Hospital Center. She completed internal medicine training at the University of Connecticut and fellowships in cardiovascular disease and interventional cardiology at Mount Sinai Medical Center.
Gonzague is a serial Medtech entrepreneur, passionate about innovation and medical technologies.Read Bio
Gonzague is a serial Medtech entrepreneur, passionate about innovation and medical technologies. He is convinced that greater gender equality in the workplace and more women in leadership positions will benefit society as a whole, and intends to be a driving force of this evolution.
Gonzague is the co-founder and Executive Chairman of <a href=”http://www.womedtech.com/”>Womed</a>, whose mission is to help women improve their fertility by protecting and restoring their uterus for pregnancy. The first product is a medical device to treat and prevent bonding of the uterine walls after surgical intervention, which is responsible for one miscarriage in five.
He was the CEO of Stentys, a company he co-founded, bringing it from inception to a successful commercial public company.
Gonzague holds an MBA from INSEAD and a Master of Science from Ecole Centrale in Paris.
<div id=”gtx-trans” style=”position: absolute; left: -14px; top: -9px;”>
Azin Parhizgar, PhD
Dr. Azin Parhizgar is a highly accomplished medical device executive and serial entrepreneur.Read Bio
Dr. Azin Parhizgar is a highly accomplished medical device executive and serial entrepreneur.
She has served as an advisor and board member to numerous emerging medtech companies as well as various academic and non-for-profit entities. Currently Dr. Parhizgar is a senior Venture Partner at 415 Capital Management, a cardiovascular focused early-stage venture investment fund, Chairman of the board of CVPath Institute, Inc. and serves as an independent director at InnovHeart S.r.l, SoundBite Medical Inc., Project Moray among other held positions.
In her five-year tenure as the President and CEO of Claret Medical, an embolic protection company, Dr. Parhizgar led the venture-backed company to a successful global commercial launch with subsequent acquisition in 2018 by Boston Scientific, Inc.
Prior to Claret Medical, she was the COO of Conor Medsystems, a reservoir based drug eluting stent Company acquired by Johnson & Johnson, Inc. in 2007. Prior to Conor Medsystems Dr. Parhizgar was Senior Vice President at Arterial Vascular Engineering (AVE), which was acquired by Medtronic Inc. in 2000. She remained with Medtronic for the following two years as Executive Vice President of Emerging Ventures and New Technologies leading key investments in early stage companies for Medtronic Vascular division.
Dr. Parhizgar earned both her Ph.D. in Cell, Gene and Tissue Engineering and her M.Sc. in Biomechanical Engineering and Artificial Organ Design from Brown University in Providence, RI, USA.
<div id=”gtx-trans” style=”position: absolute; left: -6px; top: -9px;”>
Dragica Paunovic, MD
Dr. Paunovic started her career at National blood transfusion institute (NBTI) in Belgrade Serbia...Read Bio
Dr. Paunovic started her career at National blood transfusion institute (NBTI) in Belgrade Serbia, where she was first leading emergency department at Clinical Centre of Serbia and then joined the National transplant histocompatibility centre, became a Board member of NBTI and lecturer at Belgrade University. Dr. Paunovic, continued her career in industry (Terumo Europe) as a medical advisor and progressed to the position of CMO and VP clinical and later-on Global CMO for Terumo Interventional Systems (Terumo Corporation).
Dr. Paunovic was appointed as one of the first Fellows of Terumo. During her career, she designed and managed numerous clinical trials in the areas of interventional cardiology, peripheral vascular intervention, interventional oncology, transfusion medicine, cardiac surgery, dialysis, renal and bone marrow transplantation, with always having patients benefits in mind.
Dr. Paunovic co-authored books, contributed to multiple papers in peer-reviewed journals, abstracts and presentations on national or international congresses. Areas of expertise include immunology, immuno-oncology, immuno-haematology, transfusion medicine, interventional cardiology, interventional radiology/oncology, transplantation immunology.
Dr. Paunovic has an expertise in clinical regulatory environment, risk management of medical devices and she contributed to multiple regulatory approvals of various products within different therapeutic areas. She actively participated in several academic initiatives such as Stent for life (Stent save life), Academic Research Consortium for High Bleeding Risk Patient (ARC HBR) and others.
Dr. Paunovic obtained her medical degree at Belgrade University where she also completed her residency, specialization in immuno-haematology and blood transfusion, and thesis in immunology.
Our committee structure is the backbone of our organization. Comprised of thought leaders and passionate advocates from around the world, our Committees chart our path forward and work diligently to see it through.
- J. Dawn Abbott MD Lifespan Cardiovascular Institute/Warren Alpert Medical School, Brown University Providence, RI
- Rebecca Dobson MD, MBChB Liverpool Heart & Chest Hospital NHS Foundation Trust London
- Julia Grapsa MD Guys and St Thomas NHS Trust London
- Ajay Kirtane MD, SM New York-Presbyterian Hospital/CUIMC New York, NY
- Michelle Kittleson MD Cedars Sinai Lost Angeles, CA
- Fazila Malik MBBS, MRCP National Heart Foundation Hospital & Research Institute Dhaka
- James McCabe MD University of Washington Seattle, WA
Quality Equity & Ethical Standards
- Shrilla Banerjee MD, MBBS Surrey and Sussex NHS Trust Surrey
- Sonya Burgess MBBS Nepean Public Hospital and University of New South Wales Sydney
- Robert Byrne MB BCh, PhD Mater Private Hospital Dublin
- Sharonne Hayes MD Mayo Clinic Rochester, MN
- Clara Saldarriaga MD University of Antioquia Medellín
- Rashmee Shah MD University of Utah Salt Lake City, UT
- Robert Yeh MD Beth Israel Deaconess Boston, MA
- Biykem Bozkurt MD, PhD Baylor College of Medicine Houston, TX
- Davide Capodanno MD, PhD University of Catania/Azienda Policlinico-Vittorio Emanuele Catania
- Barbara Casadei MD John Radcliffe Hospital Oxford
- Pam Douglas MD Duke University Durham, NC
- C. Michael Gibson MS, MD Baim Institute for Clinical Research Boston, MA
- Robert Harrington MD Stanford University Stanford, CA
- Tracy Wang MD, MHS, MSc Duke University Durham, NC
Research Talent Task Force
- Monica Acevedo MD Pontificia Universidad Católica de Chile Santiago
- Deepak Bhatt MD Brigham and Women’s Hospital Boston, MA
- Pamela Doulgas MD Duke University Durham, NC
- James Januzzi MD Massachusetts General Hospital Boston, MA
- Elke Platz MD Brigham and Women’s Hospital Boston, MA
- Nancy Sweitzer MD Sarver Heart Center, University of Arizona Tuscon, AZ
- Stephan Windecker MD Swiss Cardiovascular Center Bern